Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases

Virology

Volumn 372, Issue 2, 2008, Pages 384-397

  Xiao, Yong ^a,b   Chen, Gang ^a   Richard, Jonathan ^a,b   Rougeau, Nicole ^a   Li, Hongshan ^c   Seidah, Nabil G ^a   Cohen, Éric A ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

Extracellular matrix; Extracellular processing; HIV 1; Proprotein convertase; Protease; Vpr

Indexed keywords

ARGININE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; VPR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL SURFACE; CYTOPATHOGENIC EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; VIRION;

APOPTOSIS; CELL LINE; CELL MEMBRANE; G2 PHASE; HIV-1; HUMANS; PLASMIDS; PROPROTEIN CONVERTASES; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 39449117771     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.10.036     Document Type: Article

References (66)

1. Andersen J.L., and Planelles V. The role of Vpr in HIV-1 pathogenesis. Curr. HIV Res. 3 1 (2005) 43-51
2. Andersen J.L., Dehart J.L., Zimmerman E.S., Ardon O., Kim B., Jacquot G., Benichou S., and Planelles V. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Pathog. 2 12 (2006) e127
3. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., and Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3 10 (1997) 1117-1123
4. Belzile J.P., Duisit G., Rougeau N., Mercier J., Finzi A., and Cohen E.A. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4A(VPRBP) E3 ubiquitin ligase. PLoS Pathog. 3 7 (2007) e85
5. Bergeron E., Basak A., Decroly E., and Seidah N.G. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem. J. 373 Pt 2 (2003) 475-484
6. Bergeron E., Vincent M.J., Wickham L., Hamelin J., Basak A., Nichol S.T., Chretien M., and Seidah N.G. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus. Biochem. Biophys. Res. Commun. 326 3 (2005) 554-563
7. Checroune F., Yao X.J., Gottlinger H.G., Bergeron D., and Cohen E.A. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 10 1 (1995) 1-7
8. Coeytaux E., Coulaud D., Le Cam E., Danos O., and Kichler A. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J. Biol. Chem. 278 20 (2003) 18110-18116
9. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., and Haseltine W.A. Identification of HIV-1 vpr product and function. J. Acquir. Immune Defic. Syndr. 3 1 (1990) 11-18
10. Decroly E., Wouters S., Di Bello C., Lazure C., Ruysschaert J.M., and Seidah N.G. Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines. J. Biol. Chem. 271 48 (1996) 30442-30450
11. Duckert P., Brunak S., and Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 17 1 (2004) 107-112
12. Emerman M., and Malim M.H. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280 5371 (1998) 1880-1884
13. Fauci A.S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239 4840 (1988) 617-622
14. Fricker L.D., and Leiter E.H. Peptides, enzymes and obesity: new insights from a 'dead' enzyme. Trends Biochem. Sci. 24 10 (1999) 390-393
15. Gibbs J.S., Lackner A.A., Lang S.M., Simon M.A., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69 4 (1995) 2378-2383
16. Gougeon M.L. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3 5 (2003) 392-404
17. Hallenberger S., Moulard M., Sordel M., Klenk H.D., and Garten W. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. J. Virol. 71 2 (1997) 1036-1045
18. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., and Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U. S. A. 91 15 (1994) 7311-7315
19. Henklein P., Bruns K., Sherman M.P., Tessmer U., Licha K., Kopp J., de Noronha C.M., Greene W.C., Wray V., and Schubert U. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 275 41 (2000) 32016-32026
20. Hirsch V.M., Sharkey M.E., Brown C.R., Brichacek B., Goldstein S., Wakefield J., Byrum R., Elkins W.R., Hahn B.H., Lifson J.D., and Stevenson M. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat. Med. 4 12 (1998) 1401-1408
21. Hoshino S., Sun B., Konishi M., Shimura M., Segawa T., Hagiwara Y., Koyanagi Y., Iwamoto A., Mimaya J., Terunuma H., Kano S., and Ishizaka Y. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers. AIDS Res. Hum. Retroviruses 23 3 (2007) 391-397
22. Hrecka K., Gierszewska M., Srivastava S., Kozaczkiewicz L., Swanson S.K., Florens L., Washburn M.P., and Skowronski J. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc. Natl. Acad. Sci. U. S. A. 104 28 (2007) 11778-11783
23. Hrimech M., Yao X.J., Bachand F., Rougeau N., and Cohen E.A. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 73 5 (1999) 4101-4109
24. Huang M.B., Weeks O., Zhao L.J., Saltarelli M., and Bond V.C. Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J. Neurovirol. 6 3 (2000) 202-220
25. Jacotot E., Ravagnan L., Loeffler M., Ferri K.F., Vieira H.L., Zamzami N., Costantini P., Druillennec S., Hoebeke J., Briand J.P., Irinopoulou T., Daugas E., Susin S.A., Cointe D., Xie Z.H., Reed J.C., Roques B.P., and Kroemer G. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191 1 (2000) 33-46
26. Jean F., Stella K., Thomas L., Liu G., Xiang Y., Reason A.J., and Thomas G. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. U. S. A. 95 13 (1998) 7293-7298
27. Jenkins Y., Sanchez P.V., Meyer B.E., and Malim M.H. Nuclear export of human immunodeficiency virus type 1 Vpr is not required for virion packaging. J. Virol. 75 17 (2001) 8348-8352
28. Kino T., Gragerov A., Slobodskaya O., Tsopanomichalou M., Chrousos G.P., and Pavlakis G.N. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J. Virol. 76 19 (2002) 9724-9734
29. Koo B.H., Longpre J.M., Somerville R.P., Alexander J.P., Leduc R., and Apte S.S. Cell-surface processing of pro-ADAMTS9 by furin. J. Biol. Chem. 281 18 (2006) 12485-12494
30. Le Rouzic E., Belaidouni N., Estrabaud E., Morel M., Rain J.C., Transy C., and Margottin-Goguet F. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6 2 (2007) 182-188
31. Levesque K., Zhao Y.S., and Cohen E.A. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J. Biol. Chem. 278 30 (2003) 28346-28353
32. Levy D.N., Refaeli Y., MacGregor R.R., and Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 91 23 (1994) 10873-10877
33. Levy D.N., Refaeli Y., and Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69 2 (1995) 1243-1252
34. Lu Y.L., Bennett R.P., Wills J.W., Gorelick R., and Ratner L. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69 11 (1995) 6873-6879
35. Majumder B., Venkatachari N.J., Schafer E.A., Janket M.L., and Ayyavoo V. Dendritic cells infected with Vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. J. Virol. 81 14 (2007) 7388-7399
36. Mayer G., Boileau G., and Bendayan M. Sorting of furin in polarized epithelial and endothelial cells: expression beyond the Golgi apparatus. J. Histochem. Cytochem. 52 5 (2004) 567-579
37. Melikov K., and Chernomordik L.V. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell. Mol. Life Sci. 62 23 (2005) 2739-2749
38. Muthumani K., Choo A.Y., Zong W.X., Madesh M., Hwang D.S., Premkumar A., Thieu K.P., Emmanuel J., Kumar S., Thompson C.B., and Weiner D.B. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nat. Cell Biol. 8 2 (2006) 170-179
39. Nishizawa M., Kamata M., Katsumata R., and Aida Y. A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest. J. Virol. 74 13 (2000) 6058-6067
40. Nitahara-Kasahara Y., Kamata M., Yamamoto T., Zhang X., Miyamoto Y., Muneta K., Iijima S., Yoneda Y., Tsunetsugu-Yokota Y., and Aida Y. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. J. Virol. 81 10 (2007) 5284-5293
41. Nour N., Mayer G., Mort J.S., Salvas A., Mbikay M., Morrison C.J., Overall C.M., and Seidah N.G. The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases. Mol. Biol. Cell. 16 11 (2005) 5215-5226
42. Patel C.A., Mukhtar M., and Pomerantz R.J. Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74 20 (2000) 9717-9726
43. Piller S.C., Ewart G.D., Jans D.A., Gage P.W., and Cox G.B. The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 73 5 (1999) 4230-4238
44. Popov S., Rexach M., Zybarth G., Reiling N., Lee M.A., Ratner L., Lane C.M., Moore M.S., Blobel G., and Bukrinsky M. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17 4 (1998) 909-917
45. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., and Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280 15 (2005) 15300-15306
46. Richer M.J., Keays C.A., Waterhouse J., Minhas J., Hashimoto C., and Jean F. The Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin. Proc. Natl. Acad. Sci. U. S. A. 101 29 (2004) 10560-10565
47. Roshal M., Kim B., Zhu Y., Nghiem P., and Planelles V. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J. Biol. Chem. 278 28 (2003) 25879-25886
48. Schrofelbauer B., Hakata Y., and Landau N.R. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. U. S. A. 104 10 (2007) 4130-4135
49. Seidah N.G., and Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848 1-2 (1999) 45-62
50. Sherman M.P., de Noronha C.M., Pearce D., and Greene W.C. Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest. J. Virol. 74 17 (2000) 8159-8165
51. Sherman M.P., de Noronha C.M., Heusch M.I., Greene S., and Greene W.C. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 75 3 (2001) 1522-1532
52. Sherman M.P., De Noronha C.M., Williams S.A., and Greene W.C. Insights into the biology of HIV-1 viral protein R. DNA Cell Biol. 21 9 (2002) 679-688
53. Sherman M.P., Schubert U., Williams S.A., de Noronha C.M., Kreisberg J.F., Henklein P., and Greene W.C. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology 302 1 (2002) 95-105
54. Steiner D.F. The proprotein convertases. Curr. Opin. Chem. Biol. 2 1 (1998) 31-39
55. Stewart S.A., Poon B., Jowett J.B., and Chen I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71 7 (1997) 5579-5592
56. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3 10 (2002) 753-766
57. Tikhonov I., Ruckwardt T.J., Berg S., Hatfield G.S., and David Pauza C. Furin cleavage of the HIV-1 Tat protein. FEBS Lett. 565 1-3 (2004) 89-92
58. Tristem M., Purvis A., and Quicke D.L. Complex evolutionary history of primate lentiviral vpr genes. Virology 240 2 (1998) 232-237
59. Tsuji A., Hashimoto E., Ikoma T., Taniguchi T., Mori K., Nagahama M., and Matsuda Y. Inactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDX. J. Biochem. (Tokyo) 126 3 (1999) 591-603
60. Tsuji A., Sakurai K., Kiyokage E., Yamazaki T., Koide S., Toida K., Ishimura K., and Matsuda Y. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim. Biophys. Acta 1645 1 (2003) 95-104
61. Varin A., Decrion A.Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., and Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-{kappa}B and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 280 52 (2005) 42557-42567
62. Vodicka M.A., Koepp D.M., Silver P.A., and Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12 2 (1998) 175-185
63. Wen X., Duus K.M., Friedrich T.D., and de Noronha C.M. The HIV1 protein VPR acts to promote G2 cell cycle arrest by engaging a DDB1 and cullin4A containing ubiquitin ligase complex using VPRBP/DCAF1 as an adaptor. J. Biol. Chem. (2007)
64. Yao X.J., Subbramanian R.A., Rougeau N., Boisvert F., Bergeron D., and Cohen E.A. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69 11 (1995) 7032-7044
65. Yao X.J., Mouland A.J., Subbramanian R.A., Forget J., Rougeau N., Bergeron D., and Cohen E.A. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol. 72 6 (1998) 4686-4693
66. Zhu Y., Gelbard H.A., Roshal M., Pursell S., Jamieson B.D., and Planelles V. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J. Virol. 75 8 (2001) 3791-3801